Bartlett & Co’s Thermo Fisher Scientific TMO Stock Holding History

Bartlett & Co’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$92.7M	Buy	173,885 +3,541	+2%	+$1.71M	1.51%	17
2023 Q3	$86.3M	Buy	170,344 +5,234	+3%	+$2.79M	1.55%	16
2023 Q2	$86.2M	Buy	165,110 +23,369	+16%	+$12.6M	1.49%	16
2023 Q1	$81.7M	Buy	141,741 +951	+0.7%	+$536K	1.58%	15
2022 Q4	$77.6M	Buy	140,790 +7,101	+5%	+$3.76M	1.56%	15
2022 Q3	$67.8M	Sell	133,689 -17	-0%	-$9.51K	1.46%	19
2022 Q2	$72.7M	Sell	133,706 -3,580	-3%	-$1.97M	1.47%	15
2022 Q1	$81.1M	Buy	137,286 +3,490	+3%	+$2M	1.42%	17
2021 Q4	$89.3M	Sell	133,796 -543	-0.4%	-$339K	1.51%	15
2021 Q3	$76.8M	Sell	134,339 -1,606	-1%	-$881K	1.46%	17
2021 Q2	$68.6M	Buy	135,945 +106	+0.1%	+$50K	1.31%	20
2021 Q1	$62M	Sell	135,839 -2,460	-2%	-$1.17M	1.25%	22
2020 Q4	$64.4M	Sell	138,299 -152	-0.1%	-$71.3K	1.37%	17
2020 Q3	$61.1M	Buy	138,451 +318	+0.2%	+$131K	1.43%	16
2020 Q2	$50.1M	Sell	138,133 -1,519	-1%	-$509K	1.31%	19
2020 Q1	$39.6M	Buy	+139,652	New	+$44M	1.21%	25
2019 Q3	$40.7M	Buy	139,744 +85,857	+159%	+$24.6M	1.07%	24
2019 Q2	$15.8M	Buy	53,887 +52,841	+5,052%	+$14.6M	0.59%	59
2019 Q1	$286K	Buy	1,046 +78	+8%	+$19.4K	0.01%	234
2018 Q4	$217K	Sell	968 -35	-3%	-$8.21K	0.01%	246
2018 Q3	$245K	Hold	1,003	–	–	0.01%	241
2018 Q2	$208K	Buy	1,003 +200	+25%	+$42.5K	0.01%	250
2018 Q1	$166K	Hold	803	–	–	0.01%	266
2017 Q4	$152K	Hold	803	–	–	0.01%	285
2017 Q3	$152K	Sell	803 -741	-48%	-$134K	0.01%	278
2017 Q2	$269K	Hold	1,544	–	–	0.01%	230
2017 Q1	$237K	Hold	1,544	–	–	0.01%	240
2016 Q4	$218K	Sell	1,544 -84	-5%	-$12.4K	0.01%	241
2016 Q3	$259K	Hold	1,628	–	–	0.01%	231
2016 Q2	$241K	Sell	1,628 -21	-1%	-$3.1K	0.01%	233
2016 Q1	$233K	Sell	1,649 -100	-6%	-$13.4K	0.01%	234
2015 Q4	$248K	Hold	1,749	–	–	0.01%	233
2015 Q3	$214K	Sell	1,749 -37	-2%	-$4.82K	0.01%	239
2015 Q2	$232K	Hold	1,786	–	–	0.01%	240
2015 Q1	$240K	Hold	1,786	–	–	0.01%	243
2014 Q4	$224K	Sell	1,786 -283	-14%	-$34.4K	0.01%	245
2014 Q3	$252K	Hold	2,069	–	–	0.01%	233
2014 Q2	$244K	Sell	2,069 -36	-2%	-$4.24K	0.01%	242
2014 Q1	$253K	Hold	2,105	–	–	0.01%	239
2013 Q4	$234K	Sell	2,105 -17	-0.8%	-$1.69K	0.01%	243
2013 Q3	$196K	Sell	2,122 -183	-8%	-$16.5K	0.01%	248
2013 Q2	$195K	Buy	+2,305	New	+$192K	0.01%	245

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bartlett & Co's TMO Position: Q4 2023 in Review

Bartlett & Co increased its Thermo Fisher Scientific (TMO) stake by 2.1% in Q4 2023, buying an estimated $1.71M and bringing the position to 173,885 shares worth $92.7M. The position accounts for 1.51% of the portfolio, ranked #17.

Bartlett & Co first reported a position in TMO in Q2 2013 and has held it in 42 quarters since. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Bartlett & Co held 173,885 shares of Thermo Fisher Scientific worth $92.7M as of Q4 2023.
Bartlett & Co bought 3,541 Thermo Fisher Scientific shares in Q4 2023, an estimated $1.71M.
Thermo Fisher Scientific made up 1.51% of Bartlett & Co's portfolio in Q4 2023, its #17 holding.
Bartlett & Co first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 42 quarters since.
2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.